Need Help? Contact Us.

Enquire now

IDS Specific IgE (T215) rBet v 1

Product Description

An automated assay for the quantitative determination of Specific IgE in human serum on the IDS System. The results are to be used as an aid in the diagnosis and management of allergic disorders in conjunction with other clinical findings. The presence of allergen-specific IgE antibodies in serum is referred to as sensitisation and is an important risk factor for allergic reactions upon re-exposure to the allergen (1).
Associated allergens:

  • T003 Common silver birch – Betula verrucosa
  • T216 rBet v 2 – Betula verrucosa
  • Most important serological markers: automated quantitative Total and Specific IgE
  • Traceable against the WHO 2nd International Standard for Human IgE 75/502
  • Clinically relevant and most prominent allergens
  • Components and extracts for specific and sensitive results
  • Aligned closely with recognised test guidelines (2)
  • Well correlated to another supplier
  • Rapidly increasing panel
    1. Hamilton RG. Allergic sensitization is a key risk factor for but not synonymous with allergic disease. J Allergy Clin Immunol. 2014 Aug;134(2):360-1
    2. Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, Valenta R, Hilger C, et al. EAACI Molecular Allergology User’s Guide. Pediatr Allergy Immunol. 2016 May;27 Suppl 23:1-250

     

Add to Enquiry Basket

IDS Specific IgE (T215) rBet v 1

Quantity

Related Products

Assays Certification Platform Clinical Area Portfolio RUO/IVD
IDS Specific IgE (T216) rBet v 2 CE Marked iSYS Pollens Allergy IVD
This site is registered on wpml.org as a development site.